Alpha 2.0
Login Register
» Articles » PMID: 37426853

Extracorporeal Membrane Oxygenation for COVID-19 Treatment in a Community Hospital

Overview
Journal HCA Healthc J Med
Specialty Health Services
Date 2023 Jul 10
PMID 37426853
Authors
Daniel I Loube
Kashif Z Hassan
Sang H Lee
Affiliations
Soon will be listed here.
Abstract

Description Coronavirus disease 2019 (COVID-19) may result in severe acute respiratory disease syndrome (ARDS) and death. For COVID-19 patients failing mechanical ventilation, extra corporeal membrane oxygenation (ECMO) has been used with varying efficacy in academic medical centers and quaternary referral centers. We report the successful use of veno-venous (VV) ECMO to treat refractory ARDS due to COVID-19 in a community hospital setting with a survival to discharge rate of 71% over a 3 month period. In a community hospital with adequate resources, VV ECMO can be an effective rescue therapy for selected COVID-19 patients who fail all other available treatments.

Citing Articles

Fit-for-Future: Lessons Learned from the COVID-19 Pandemic in Primary Extracorporeal Membrane Oxygenation (ECMO) Transports of Acute Respiratory Distress Syndrome (ARDS) Patients.

Muenster S, Schumacher S, Schmandt M, Kreyer S, Poth J, Putensen C J Clin Med. 2024; 13(18).

PMID: 39336878 PMC: 11432369. DOI: 10.3390/jcm13185391.

Cardiac Extracorporeal Membrane Oxygenation in Community Cardiac Surgery Program: Are the Results Comparable?.

Rizvi S, Nagle M, Roberts B, McDermott L, Miller K, Pasquarello C Cureus. 2024; 16(4):e58947.

PMID: 38800214 PMC: 11126332. DOI: 10.7759/cureus.58947.

References
1.
Jacobs J, Stammers A, Louis J, Awori Hayanga J, Firstenberg M, Mongero L . Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in Coronavirus Disease 2019: Experience with 32 Patients. ASAIO J. 2020; 66(7):722-730. PMC: 7217117. DOI: 10.1097/MAT.0000000000001185. View
2.
Montisci A, Maj G, Zangrillo A, Winterton D, Pappalardo F . Management of refractory hypoxemia during venovenous extracorporeal membrane oxygenation for ARDS. ASAIO J. 2015; 61(3):227-36. DOI: 10.1097/MAT.0000000000000207. View
3.
DellaVolpe J, Barbaro R, Cannon J, Fan E, Greene W, Gunnerson K . Joint Society of Critical Care Medicine-Extracorporeal Life Support Organization Task Force Position Paper on the Role of the Intensivist in the Initiation and Management of Extracorporeal Membrane Oxygenation. Crit Care Med. 2020; 48(6):838-846. PMC: 7422732. DOI: 10.1097/CCM.0000000000004330. View
4.
Cho H, Heinsar S, Jeong I, Shekar K, Li Bassi G, Jung J . ECMO use in COVID-19: lessons from past respiratory virus outbreaks-a narrative review. Crit Care. 2020; 24(1):301. PMC: 7275850. DOI: 10.1186/s13054-020-02979-3. View
5.
Li X, Guo Z, Li B, Zhang X, Tian R, Wu W . Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 in Shanghai, China. ASAIO J. 2020; 66(5):475-481. PMC: 7273861. DOI: 10.1097/MAT.0000000000001172. View